Real-time Stock quotes, portfolio, LIVE TV and more.
|
|
| 5-Day | 151,239 |
| 10-Day | 185,107 |
| 30-Day | 114,873 |
| 5-Day | 151,239 |
| 10-Day | 185,107 |
| 30-Day | 114,873 |
| 5-Day | 1,321,923 |
| 10-Day | 1,324,184 |
| 30-Day | 860,473 |
| 5-Day | 1,321,923 |
| 10-Day | 1,324,184 |
| 30-Day | 860,473 |
| Days | BSE | NSE |
| 30 | 449.92 | 450.18 |
| 50 | 444.23 | 444.44 |
| 150 | 472.11 | 472.29 |
| 200 | 487.26 | 487.45 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Ranbaxy Labs
| (Mar '13) Quarterly |
(Dec '12) Yearly |
|
| Net Sales | 1381.64 | 6303.54 |
| Other Income | 52.33 | 239.60 |
| PBDIT | 84.21 | 700.08 |
| Net Profit | 70.15 | -162.34 |
| Total Share Capital | 211.46 |
| Net Worth | 1922.08 |
| Total Debt | 4763.61 |
| Net Block | 1993.53 |
| Investments | 3131.17 |
| Net Current Assets | 1401.38 |
| Total Assets | 6685.68 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 1001.90 | 2.90 | 1013.10 | 569.00 | 103,754.96 |
| Dr Reddys Labs | 2056.55 | 1.84 | 2150.90 | 1555.00 | 34,927.72 |
| Lupin | 768.50 | -0.05 | 810.80 | 519.00 | 34,400.91 |
| Cipla | 415.25 | -0.44 | 435.00 | 305.00 | 33,341.31 |
| GlaxoSmithKline | 2277.45 | 0.07 | 2522.00 | 2005.00 | 19,290.69 |
| More » | |||||
| Mar' 13 | Dec' 12 | Sep' 12 | Jun' 12 | |
| Promoter | 63.52 | 63.54 | 63.64 | 63.66 |
| FII | 10.55 | 10.65 | 10.57 | 9.66 |
| DII | 10.03 | 10.39 | 10.63 | 11.08 |
| Others | 15.90 | 15.42 | 15.16 | 15.60 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| Scheme | No. of Shares |
| Reliance Growth Fund - Retail Plan (G) | 3,074,941 |
| Reliance Equity Opportunities Fund - Retail Plan (G) | 2,251,826 |
| Reliance Pharma Fund (G) | 1,500,600 |
| Reliance Top 200 Fund - Retail Plan (G) | 581,121 |